UCLA Hematology/Oncology - Parkside is a clinical research site located in Santa Monica, California, United States 90404.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
UCLA Hematology/Oncology - Parkside has participated in 8 clinical trials with 5 currently active.
Therapeutic areas: HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer, Breast Neoplasms, BRCA 1 Gene Mutation.
Sponsors: Pfizer, Eli Lilly and Company, Seagen, a wholly owned subsidiary of Pfizer.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
UCLA Hematology/Oncology - Parkside has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UCLA Hematology/Oncology - Parkside has 8 clinical trials on record, with 5 currently active. Their work covers HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer, Breast Neoplasms, BRCA 1 Gene Mutation.
Yes — UCLA Hematology/Oncology - Parkside holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.